Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: a meta-analysis of the risk factors.
about
Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogenFatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVManaging dyslipidemia in HIV/AIDS patients: challenges and solutionsHuman immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.Risk factors for fatty liver in the Multicenter AIDS Cohort Study.HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologiesShort Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons.Progression of liver fibrosis in HIV/HCV genotype 1 co-infected patients is related to the T allele of the rs12979860 polymorphism of the IL28B gene.Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse.Changes in liver steatosis evaluated by transient elastography with the controlled attenuation parameter in HIV-infected patients.Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients.Liver fibrosis and fatty liver in Asian HIV-infected patients.Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients.Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis.
P2860
Q26861095-DF721723-B91C-455B-9AE7-4EBBD7070976Q28079826-8AE936F4-5FB6-42C9-A065-B9A2FE26F772Q28084941-60C7F7FC-E0EC-4FA1-B959-A63AD1E966A2Q31149395-EFB19E64-2BA7-431D-93B4-C5B2962CE76FQ34049896-E988AEE2-FC76-4D09-A45F-8E423F8A2EA7Q34561257-94EB49DF-743C-4735-8AF9-0D3B0701E19EQ35861534-AACFB0AB-BB6B-463E-A036-87A19A274947Q35959126-46D77A3D-2903-4DE2-BA52-F9D070E0C197Q36532400-3E1E06EF-26EB-42BA-A762-B5691C2CE22AQ39877513-A1E1BCB2-0541-4B92-82D5-29E5BFC7B1E5Q40360505-F4C0254F-B56A-463C-91BB-82D6D5FA7405Q40701523-D6AF5F11-11D1-4785-A607-4A88B872F76DQ45358296-CB4BA421-4104-41D6-ADCE-68362E0D8EF7Q54226681-BC40AC47-6625-429E-B8A8-EFEBFE3313CA
P2860
Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: a meta-analysis of the risk factors.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Hepatic steatosis in patients ...... -analysis of the risk factors.
@en
Hepatic steatosis in patients ...... -analysis of the risk factors.
@nl
type
label
Hepatic steatosis in patients ...... -analysis of the risk factors.
@en
Hepatic steatosis in patients ...... -analysis of the risk factors.
@nl
prefLabel
Hepatic steatosis in patients ...... -analysis of the risk factors.
@en
Hepatic steatosis in patients ...... -analysis of the risk factors.
@nl
P2860
P356
P1433
P1476
Hepatic steatosis in patients ...... a-analysis of the risk factors
@en
P2093
Mariana Verdelho Machado
P2860
P356
10.1002/HEP.23619
P407
P577
2010-07-01T00:00:00Z